Working… Menu

A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02471846
Recruitment Status : Completed
First Posted : June 15, 2015
Last Update Posted : October 22, 2019
Information provided by (Responsible Party):
Genentech, Inc.